483 Response Taro Pharmaceuticals Sep 2001

Arlene Badillo FDA$119.00 - Available Now

FDA investigators audited the Taro Pharmaceuticals - Brampton, Canada facility and issued inspectional observation (via FDA 483) on 14 Sep 2001.

Product details

  • Category:
  • Inspection end: 14 Sep 2001
  • Location: Brampton, Canada
  • FEI: 3002808384
Add To Cart